account_balance
Investment manager · 13F filer · SEC CIK 2018299
Boxer Capital Management, LLC
Reported value$1.33Bas of Jun 30, 2026
Positions63 12 new, 3 sold out
Top 10 weight65.1%TNGX alone is 26%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
TNGXTango Therapeutics Inc
25.6%
RVMDRevolution Medicines Inc
7.1%
ABVXAbivax SA
6.1%Added +202%
QUREUniqure NV
5.2%Added +127%
KODKodiak Sciences Inc
4.3%Added +9%
KYMRKymera Therapeutics Inc
3.7%Added +30%
DFTXDefinium Therapeutics Inc
3.5%Added +67%
REPLReplimune Group Inc
3.3%Added +239%
CELCCelcuity Inc
3.3%Added +85%
QTTBQ32 Bio Inc
3.0%New
CAPRCapricor Therapeutics Inc
2.5%Added +136%
PGENPrecigen Inc
2.2%Added +47%
TNGXTango Therapeutics Inc
25.6%
RVMD7.1%ABVX6.1%QURE5.2%KOD4.3%KYMR3.7%DFTX3.5%REPL3.3%CELC3.3%QTTB3.0%CAPR2.5%PGEN2.2%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
TNGX Tango Therapeutics Inc 25.6% HeldRVMD Revolution Medicines Inc 7.1% HeldABVX Abivax SA 6.1% Added +202%QURE Uniqure NV 5.2% Added +127%KOD Kodiak Sciences Inc 4.3% Added +9%KYMR Kymera Therapeutics Inc 3.7% Added +30%DFTX Definium Therapeutics Inc 3.5% Added +67%REPL Replimune Group Inc 3.3% Added +239%CELC Celcuity Inc 3.3% Added +85%QTTB Q32 Bio Inc 3.0% NewCAPR Capricor Therapeutics Inc 2.5% Added +136%PGEN Precigen Inc 2.2% Added +47%
What changed